Literature DB >> 33442002

Liver metastases inhibit immunotherapy efficacy.

Katherine E Lindblad1,2,3,4, Amaia Lujambio5,6,7,8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33442002     DOI: 10.1038/s41591-020-01190-9

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients.

Authors:  Andrea De Giglio; Chiara Deiana; Alessandro Di Federico
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-24       Impact factor: 4.553

2.  Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients.

Authors:  Paweł Rogala; Anna M Czarnecka; Bożena Cybulska-Stopa; Krzysztof Ostaszewski; Karolina Piejko; Marcin Ziętek; Robert Dziura; Ewa Rutkowska; Łukasz Galus; Natasza Kempa-Kamińska; Joanna Seredyńska; Wiesław Bal; Katarzyna Kozak; Anna Surus-Hyla; Tomasz Kubiatowski; Grażyna Kamińska-Winciorek; Rafał Suwiński; Jacek Mackiewicz; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

3.  Clinical determinants of long-term survival in metastatic uveal melanoma.

Authors:  Elias A T Koch; Anne Petzold; Anja Wessely; Edgar Dippel; Michael Erdmann; Lucie Heinzerling; Bettina Hohberger; Harald Knorr; Ulrike Leiter; Friedegund Meier; Peter Mohr; Farnaz Rahimi; Beatrice Schell; Max Schlaak; Patrick Terheyden; Beatrice Schuler-Thurner; Selma Ugurel; Jochen Utikal; Julio Vera; Michael Weichenthal; Fabian Ziller; Carola Berking; Markus V Heppt
Journal:  Cancer Immunol Immunother       Date:  2021-10-28       Impact factor: 6.630

4.  Multi-perspective comparison of the immune microenvironment of primary colorectal cancer and liver metastases.

Authors:  Yangsong He; Yanan Han; A-Hui Fan; Danxiu Li; Boda Wang; Kun Ji; Xin Wang; Xiaodi Zhao; Yuanyuan Lu
Journal:  J Transl Med       Date:  2022-10-04       Impact factor: 8.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.